Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T19:28:24.659Z.
Calculation as of: 2026-10-06T19:28:24.659Z.
Quote observation: 2026-10-06T19:25:13.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: dca1631eda29ddb718d1613c57238547212c9a7381b4d8f04f2ed5a2c46bc485
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
Market Cap
$691.32M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$690.48M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$701.24M
EV/EBITDA Ratio
N/A
TTM Avg
316.20x
3Y Avg
225.87x
5Y Avg
225.87x
Market Cap
$710.02M
EV/EBITDA Ratio
2.85x
TTM Avg
4.78x
3Y Avg
5.46x
5Y Avg
7.57x
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Wave Life Sciences Ltd. (WVE) | $689.67M | N/A | N/A | N/A | N/A |
| Anteris Technologies Global Corp. (AVR)vs › | $691.32M | N/A | N/A | N/A | N/A |
| Olema Pharmaceuticals, Inc. (OLMA)vs › | $690.48M | N/A | N/A | N/A | N/A |
| Verastem, Inc. (VSTM)vs › | $684.54M | N/A | N/A | N/A | N/A |
| Faeth Therapeutics, Inc. (FTH)vs › | $696.54M | N/A | N/A | N/A | N/A |
| ArriVent BioPharma, Inc. (AVBP)vs › | $680.93M | N/A | N/A | N/A | N/A |
| Solid Biosciences Inc. (SLDB)vs › | $679.79M | N/A | N/A | N/A | N/A |
| Cytek Biosciences, Inc. (CTKB)vs › | $701.24M | N/A | 316.20x | 225.87x | 225.87x |
| Collegium Pharmaceutical, Inc. (COLL)vs › | $710.02M | 2.85x | 4.78x | 5.46x | 7.57x |
| Avalo Therapeutics, Inc. (AVTX)vs › | $711.74M | N/A | 867.40x | 862.35x | 862.35x |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
